Related Experiment Video
Updated: Jun 17, 2026
05:47
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Computational toxicology methods in public health practice.
Eugene Demchuk1, Patricia Ruiz, Jewell D Wilson
1Division of Toxicology and Environmental Medicine, Agency for Toxic Substances and Disease Registry, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Toxicology Mechanisms and Methods
|December 22, 2009
Summary
Computational toxicology models enhance traditional animal testing for hazard identification and health risk assessment. These advanced methods reduce uncertainty and evaluate untested chemicals for public health assessments.
Area of Science:
- Toxicology
- Computational Biology
- Risk Assessment
Background:
- Traditional toxicology relies on animal testing, which is time-consuming, expensive, and involves uncertainty due to interspecies differences.
- Many chemicals remain untested, leaving gaps in public health assessments.
Purpose of the Study:
- To present advanced computational models developed by the Agency for Toxic Substances and Disease Registry (ATSDR).
- To demonstrate how these models augment traditional toxicological approaches for improved hazard identification and health risk assessment.
Main Methods:
- Utilizing multilevel cross-extrapolation techniques within computational models.
- Integrating computational approaches to analyze toxic agents and their mechanisms of action.
Main Results:
- Computational models reduce uncertainty in experimental testing.
- These models enable the assessment of previously untested chemicals.
- Improved understanding of toxicological modes of action and injury mechanisms.
Conclusions:
- Advanced computational toxicology offers a more efficient and comprehensive approach to hazard identification and risk assessment.
- The integration of computational models enhances the scientific basis for public health guidance documents, such as Toxicological Profiles.
Related Concept Videos
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:21Toxicokinetics: Overview
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
01:36Types of Toxins
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:24Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...